Women's Health 2021: Beyond the Annual Visit - Midwest

During any visit, we must use a far broader lens on issues facing the female patient. That’s why there’s Women’s Health 2021: Beyond the Annual Visit.

Live Broadcast
6.00 available credits
Information
October 22, 2021
08:00 AM - 04:00 PM CDT
Online
Midwest
ReachMD Healthcare Image

This live broadcast will start in exactly:

  • 0

    Day(s)

  • 0

    Hour(s)

  • 0

    Minute(s)

  • 0

    Second(s)

Choose a format
Details
Presenters
Comments
  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2021: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts who discuss the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible care for the whole female patient.

    We're excited to announce Dr. Anita Nelson as this year's Program Director and Moderator!

    Join the conversation #WH21

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:

    Anita L. Nelson, MD
    Professor
    Department of Obstetrics and Gynecology
    Harbor-UCLA Medical Center
    Torrance, CA
    Consulting Fees: Agile Therapeutics, AMAG, American Regent, Bayer HealthCare, Merck, Sebela Pharmaceutical, TherapeuticsMD                                        
    Commercial Interest Speakers Bureau: American Regent, Bayer HealthCare, Merck, TherapeuticsMD
    Contracted Research: Agile Therapeutics, EvoFem, Merck, Mithra, Sebela Pharmaceutical

    Faculty:

    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University School of Medicine in St. Louis
    St. Louis, MO
    Consulting Fees: Evofem, Femosys, Medicines360, Sebela Pharmaceuticals Inc./ACI Clinical
    Commercial Interest Speakers Bureau: Evofem, Merck
    Contracted Research: Medinines360, Merck
    Ownership Interest: Femosys

    Brooke M. Faught, DNP, WHNP, NCMP, FAANP, IF
    Director of the Women’s Institute for Sexual Health (WISH)
    Nashville, TN
    Consulting Fees: Mayne Pharm, SCYNEXIS, Trophikos
    Speakers Bureau: Agile Therapeutics, JDS Therapeutics, Palatin, Therapeutics MD
    Contracted Research: Dare Bioscience, IPSEN Innovation

    Paul Nyirjesy, MD
    Professor of Obstetrics & Gynecology
    Co-director, Jefferson Vulvovaginal Health Center
    Sidney Kimmel Medical College at Thomas Jefferson University
    Philadelphia, PA
    Consulting Fees: Hologic, Inc., Mycovia Pharmaceuticals, SCYNEXIS, Inc.

    Gregory S Pokrywka MD, FACP, FNLA, FASPC, NCMP
    Director: Baltimore Lipid Center
    Assistant Professor
    Johns Hopkins University School of Medicine
    Baltimore, MD
    Commercial Interest Speakers Bureau: Amarin, Amgen, Esperion 

    Karol Watson, MD, PhD
    Professor of Medicine/Cardiology
    Co-director, UCLA Program in Preventive Cardiology
    Director, UCLA Barbra Streisand Women's Heart Health Program
    David Geffen School of Medicine at UCLA
    Los Angeles, CA
    Consulting Fees: Amarin, Amgen, Boehringer-Ingelheim, Lilly, Esperion, Nova Nordisk

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Ben Caref, PhD, has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose.

  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, family practice, and internal medicine.

  • Commercial Support

    This activity is supported by independent educational grants from Agile Therapeutics, Amarin, Biohaven Pharmaceuticals, Evofem Biosciences, and SCYNEXIS.

Facebook Comments

Details
Presenters
Comments
  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2021: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts who discuss the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible care for the whole female patient.

    We're excited to announce Dr. Anita Nelson as this year's Program Director and Moderator!

    Join the conversation #WH21

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:

    Anita L. Nelson, MD
    Professor
    Department of Obstetrics and Gynecology
    Harbor-UCLA Medical Center
    Torrance, CA
    Consulting Fees: Agile Therapeutics, AMAG, American Regent, Bayer HealthCare, Merck, Sebela Pharmaceutical, TherapeuticsMD                                        
    Commercial Interest Speakers Bureau: American Regent, Bayer HealthCare, Merck, TherapeuticsMD
    Contracted Research: Agile Therapeutics, EvoFem, Merck, Mithra, Sebela Pharmaceutical

    Faculty:

    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University School of Medicine in St. Louis
    St. Louis, MO
    Consulting Fees: Evofem, Femosys, Medicines360, Sebela Pharmaceuticals Inc./ACI Clinical
    Commercial Interest Speakers Bureau: Evofem, Merck
    Contracted Research: Medinines360, Merck
    Ownership Interest: Femosys

    Brooke M. Faught, DNP, WHNP, NCMP, FAANP, IF
    Director of the Women’s Institute for Sexual Health (WISH)
    Nashville, TN
    Consulting Fees: Mayne Pharm, SCYNEXIS, Trophikos
    Speakers Bureau: Agile Therapeutics, JDS Therapeutics, Palatin, Therapeutics MD
    Contracted Research: Dare Bioscience, IPSEN Innovation

    Paul Nyirjesy, MD
    Professor of Obstetrics & Gynecology
    Co-director, Jefferson Vulvovaginal Health Center
    Sidney Kimmel Medical College at Thomas Jefferson University
    Philadelphia, PA
    Consulting Fees: Hologic, Inc., Mycovia Pharmaceuticals, SCYNEXIS, Inc.

    Gregory S Pokrywka MD, FACP, FNLA, FASPC, NCMP
    Director: Baltimore Lipid Center
    Assistant Professor
    Johns Hopkins University School of Medicine
    Baltimore, MD
    Commercial Interest Speakers Bureau: Amarin, Amgen, Esperion 

    Karol Watson, MD, PhD
    Professor of Medicine/Cardiology
    Co-director, UCLA Program in Preventive Cardiology
    Director, UCLA Barbra Streisand Women's Heart Health Program
    David Geffen School of Medicine at UCLA
    Los Angeles, CA
    Consulting Fees: Amarin, Amgen, Boehringer-Ingelheim, Lilly, Esperion, Nova Nordisk

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Ben Caref, PhD, has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Libby Lurwick has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose.

  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, family practice, and internal medicine.

  • Commercial Support

    This activity is supported by independent educational grants from Agile Therapeutics, Amarin, Biohaven Pharmaceuticals, Evofem Biosciences, and SCYNEXIS.

Facebook Comments

Register

We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free